FDA NDC Directory · JSON-LD · Markdown

Zanaflex

NDC 70515-604 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nametizanidine hydrochloride
Labeler / ManufacturerCovis Pharma US, Inc
Marketing categoryNew Drug Application (innovator) · App NDA021447
Dosage form / routeCAPSULE · ORAL
Active ingredientsTIZANIDINE HYDROCHLORIDE (4 mg/1)
Marketing started20180801
Package count1

External sources

Source: openFDA. Public-domain (CC0).